To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Departmental Publication (Guidance and Regulation)
Department for Work and Pensions

Apr. 09 2024

Source Page: Employing disabled people: Disability Confident and CIPD manager’s guide
Document: Recruiting, managing and developing disabled people: a practical guide for managers [accessible PDF] (PDF)

Found: by their impairment, for example, instead of saying ‘she is diabetic’ it is better to say ‘she has diabetes

Scottish Parliament Written Question
S6W-26354
Tuesday 9th April 2024

Asked by: Briggs, Miles (Scottish Conservative and Unionist Party - Lothian)

Question

To ask the Scottish Government (a) how many and (b) what percentage of patients diagnosed with diabetes have been provided real-time glucose monitoring devices in each NHS board in each year since 1999.

Answered by Minto, Jenni - Minister for Public Health and Women's Health

This information is not held centrally.

Some information on the percentage of people using glucose monitors and other diabetes technologies can be found in the Scottish Diabetes Survey, which provides an annual summary of key issues and trends in diabetes care and treatment in Scotland. The Survey provides annual data going back to 2004 and can be found here: https://www.diabetesinscotland.org.uk/publications/#survey-docs.

The next iteration of the Survey, covering data for 2023, will be published later this year.

Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: National Patient Safety Alert: ​​Reducing risks for transfusion-associated circulatory overload​ ​(NatPSA/2024/004/MHRA​)
Document: TACO Chapter (PDF)

Found: Case 13c.1: An elderly man with renal failure An 82 year old man with type-2 diabetes, sepsis and acute

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: M4E(R2) – CTD on Efficacy (PDF)

Found: large number of subjects with a given co - morbid condition such as hypertension, heart disease, or diabetes

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: M3(R2) – Questions and Answers (R2) (PDF)

Found: add-on therapy to the standard of care or combination therapy is common, such as with hypertension, diabetes

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: E11(R1) – Clinical Investigation of Medicinal Products in the Pediatric Populations: Guideline and Addendum (PDF)

Found: are also influenced by the hormonal changes around puberty (e.g., increases in insulin resistance in diabetes

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: E15 – Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories (PDF)

Found: limited clinical data can be associated with anonymous samples (e.g., samples from subjects with diabetes

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: E3 – Structure and Content of Clinical Study Reports (PDF)

Found: prognosis or response to therapy − concomitant illness at trial initiation, such as renal disease, diabetes

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: Q3D(R2) – Guideline for Elemental Impurities (PDF)

Found: deficiency causes changes in the metabolism of glucose and lipids and may be associated with maturity-onset diabetes

Non-Departmental Publication (Guidance and Regulation)
Ofqual

Apr. 03 2024

Source Page: VTQ information hub 2023 to 2024: key dates and deadlines
Document: (webpage)

Found: Aug-24 19-Aug-24 N/A NCFE NCFE CACHE Level 3 Certificate in Understanding the Care and Management of Diabetes